PharmacoEconomics & Outcomes News

, Volume 800, Issue 1, pp 17–17 | Cite as

Cost effectiveness of adult PCV13 vax affected by serotype changes

Clinical study


  1. Chen C, et al. Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination. Vaccine : 13 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations